Alex H Li - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Alex H Li

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Frontiers in Oncology|April 25, 2022

Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer TreatmentAnthony J Murphy, Alex H Li, Peichao Li, et al.

International Journal of Molecular Sciences|February 10, 2024

Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer CellsAlex H Li, Sun Young Park, Peiwei Li, et al.

Acta Pharmacologica Sinica|January 16, 2024

Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancerLing-Bing Li, Ling-Xiao Yang, Lei Liu, et al.

Oncogene|February 5, 2024

Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signalingPeichao Li, Lingxiao Yang, Sun Young Park, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Frontiers in Oncology|April 25, 2022

Therapeutic Targeting of Alternative Splicing: A New Frontier in Cancer TreatmentAnthony J Murphy, Alex H Li, Peichao Li, et al.

International Journal of Molecular Sciences|February 10, 2024

Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on Highly Invasive Human T24 Bladder Cancer CellsAlex H Li, Sun Young Park, Peiwei Li, et al.

Acta Pharmacologica Sinica|January 16, 2024

Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancerLing-Bing Li, Ling-Xiao Yang, Lei Liu, et al.

Oncogene|February 5, 2024

Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signalingPeichao Li, Lingxiao Yang, Sun Young Park, et al.

Pageof 1